Adial Pharmaceuticals
ADIL
$1.22
Share price
-2.40%
Change (1 day)
351.85%
Change (1 year)
Categories
Adial Pharmaceuticals (ADIL) - Cash on Hand
Cash on Hand as of March 2024 : $5.02 M
According to Adial Pharmaceuticals
's latest financial reports the company has $5.02 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Adial Pharmaceuticals - Cash on Hand chart (from 2016 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $4 M | -33.99% |
| 2021-12-31 | $6.06 M | 37.74% |
| 2020-12-31 | $4.4 M | -35.06% |
| 2019-12-31 | $6.77 M | 75.16% |
| 2018-12-31 | $3.86 M | 21102.56% |
| 2017-12-31 | $0.01 M | -79.26% |
| 2016-12-31 | $0.08 M | -45.81% |
| 2015-12-31 | $0.16 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.13 M | -97.37% | Bahamas |
 NRC Health
NRC | $1.69 M | -66.19% | 🇺🇸 USA |